Top 10 Stocks to Buy According to Ariel Investments
Long-term bond yields have risen significantly to the highest level since 2007. The rise has coincided with significant gains in the equity markets.
Prestige Consumer Healthcare Inc. (PBH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Easterly Partners John Murphy | 18,400 | $869,768 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.90 | 1,500 | $50,850.00 | 6,600 | 2018-02-12 | Filing | |
| $37.04 | 3,000 | $111,120.00 | 7,806 | 2018-02-07 | Filing | |
| $35.47 | 4,200 | $148,974.00 | 11,097 | 2018-02-05 | Filing | |
| $35.94 | 7,000 | $251,580.00 | 138,969 | 2018-02-05 | Filing | |
| $35.47 | 7,500 | $266,025.00 | 38,506 | 2018-02-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $52.28 | 351 | $18,350.28 | 41,810 | 2026-05-11 | Filing | |
| $54.36 | 305 | $16,579.80 | 42,161 | 2026-05-07 | Filing | |
| $54.99 | 1,207 | $66,372.93 | 42,820 | 2026-05-05 | Filing | |
| $55.32 | 346 | $19,140.72 | 44,334 | 2026-05-05 | Filing | |
| $65.93 | 1,000 | $65,930.00 | 41,048 | 2026-02-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 609,949 | $28,832,289 | 0.22% | |
| 2. | 252,984 | $11,958,554 | 0.98% | |
| 3. | 75,121 | $3,550,984 | 0.13% | |
| 4. | 61,203 | $2,893,066 | 0.05% | |
| 5. | 33,410 | $1,980,211 | 0.12% |
News See All
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
TheFly reported on May 15 that Canaccord Genuity cut its price target on PBH from $86 down to $72 while keeping a Buy rating in place.
11 Most Undervalued Pharma Stocks to Invest In
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Prestige Consumer Healthcare, Inc. Fourth Quarter 2026 Earnings Conference Call.
Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5%
Heartland Advisors, an investment management company, released its “Heartland Opportunistic Value Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here...
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)'s Quarterly Revenue
TheFly reported on February 6 that Canaccord reduced its price target on PBH to $86 from $88 and maintained a Buy rating on the shares. The change came after the company reported fiscal third-quarter...
15 Innovative Healthcare Stocks to Buy According to Analysts
Over the last two years, artificial intelligence has propelled global financial markets into a boom, with stocks reaching all-time highs.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2026 Earnings Call Transcript February 5, 2026Prestige Consumer Healthcare Inc. misses on earnings expectations.
Prestige Consumer Healthcare Inc. (PBH): A Bull Case Theory
We came across a bullish thesis on Prestige Consumer Healthcare Inc. on CopyCat Invest’s Substack. In this article, we will summarize the bulls’ thesis on PBH.
Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (NYSE:PBH) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Prestige Consumer Healthcare Inc.
Hedge Fund Resource Center